Antibiotic Vancomycin Articles & Analysis: Older
6 news found
The Centers for Disease Control and Prevention (CDC) warns these bacteria are constantly finding new ways to avoid the effects of the antibiotics used to treat those infections. Vancomycin-resistant enterococci (VRE) is the name for the bacteria resistant to the antibiotic known as vancomycin. When the CDC released the 2019 ...
Subjects received a low dose, high dose, or placebo for one or 14 days, with or without vancomycin antibiotic pretreatment, and were followed for six months after treatment. ...
A pre-planned exploratory analysis from the ECOSPOR III trial shows that approximately two-thirds of CDI recurrences occurred within the first two weeks following antibiotic treatment for CDI – the window of vulnerability – when the microbiome is further decimated and C. difficile spores, untouched by antibiotics, are free to germinate into ...
ALS-4 is targeted for potential administration on a standalone or on a combination basis with other existing antibiotics such as vancomycin. About SACT-1 SACT-1 is an orally administered repurposed small molecule drug to target neuroblastoma. ...
Although they may be a common part of the bacterial mix that is often found in and on parts of the human body, they can however, sometimes cause serious infections. Vancomycin is an antibiotic that is used to treat some drug-resistant infections caused by Enterococci. In some instances, Enterococci have become resistant to this drug and are thus called ...
Methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (C. diff) have received much of the public’s attention, but increasingly vancomycin-resistant enterococci (VRE) has come under the spotlight. ...